Here’s What This Label Expansion Could Mean for Eli Lilly Investors
Jardiance, a medication well-known for treatment of type 2 diabetes, now has another importance use. This past month, Eli Lilly(NYSE:LLY) and its German partner Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) had approved…
